Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 193561 | Peak area | PAK | Untreated |
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 205444 | Peak area | PAK | TNF-alpha |
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 211678 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 216020 | Peak area | BS4 | Untreated |
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 224970 | Peak area | HAHA | Untreated |
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 225677 | Peak area | PAK | IL-17A |
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 230306 | Peak area | HAHA | TNF-alpha |
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 231484 | Peak area | HAHA | IL-17A |
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 232360 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 251303 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 274589 | Peak area | BS4 | IFN-G |
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 291262 | Peak area | BS4 | IL-17A |
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 291537 | Peak area | HAHA | IFN-G |
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 292761 | Peak area | BS4 | TNF-alpha |
Reversed phase NEGATIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)- | 530288 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | 31049 | Peak area | HAHA | TNF-alpha |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | 53037 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | Peak area | BS4 | IFN-G | |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | Peak area | BS4 | IL-17A | |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | Peak area | BS4 | TNF-alpha | |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | Peak area | BS4 | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | Peak area | BS4 | Untreated | |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | Peak area | HAHA | IFN-G | |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | Peak area | HAHA | IL-17A | |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | Peak area | HAHA | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | Peak area | HAHA | Untreated | |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | Peak area | PAK | IL-17A | |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | Peak area | PAK | TNF-alpha | |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | Peak area | PAK | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+ | Peak area | PAK | Untreated |